AU2002236534A1 - Compositions and methods relating to ovary specific genes and proteins - Google Patents
Compositions and methods relating to ovary specific genes and proteinsInfo
- Publication number
- AU2002236534A1 AU2002236534A1 AU2002236534A AU3653402A AU2002236534A1 AU 2002236534 A1 AU2002236534 A1 AU 2002236534A1 AU 2002236534 A AU2002236534 A AU 2002236534A AU 3653402 A AU3653402 A AU 3653402A AU 2002236534 A1 AU2002236534 A1 AU 2002236534A1
- Authority
- AU
- Australia
- Prior art keywords
- proteins
- compositions
- specific genes
- methods relating
- ovary specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000623 proteins and genes Proteins 0.000 title 2
- 239000000203 mixture Substances 0.000 title 1
- 210000001672 ovary Anatomy 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24999700P | 2000-11-20 | 2000-11-20 | |
US60/249,997 | 2000-11-20 | ||
PCT/US2001/045010 WO2002040720A2 (en) | 2000-11-20 | 2001-11-20 | Compositions and methods relating to ovary specific genes and proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002236534A1 true AU2002236534A1 (en) | 2002-05-27 |
Family
ID=22945875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002236534A Abandoned AU2002236534A1 (en) | 2000-11-20 | 2001-11-20 | Compositions and methods relating to ovary specific genes and proteins |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020160387A1 (en) |
AU (1) | AU2002236534A1 (en) |
WO (1) | WO2002040720A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2339028A1 (en) | 2001-09-14 | 2011-06-29 | Clinical Genomics Pty. Ltd | Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
WO2016130899A1 (en) | 2015-02-13 | 2016-08-18 | The Board Of Trustees Of The University Of Illinois | Peptide inhibition of ccr3-mediated diseases or conditions |
WO2021150713A2 (en) * | 2020-01-21 | 2021-07-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human immunogenic epitopes of h, k, and e human endogenous retroviruses (hervs) |
-
2001
- 2001-11-20 WO PCT/US2001/045010 patent/WO2002040720A2/en not_active Application Discontinuation
- 2001-11-20 US US10/001,835 patent/US20020160387A1/en not_active Abandoned
- 2001-11-20 AU AU2002236534A patent/AU2002236534A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002040720A2 (en) | 2002-05-23 |
US20020160387A1 (en) | 2002-10-31 |
WO2002040720A8 (en) | 2003-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001292842A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002249787A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
AU2002245031A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002219988A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2002243972A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2001297741A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2002220009A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
AU2002239409A1 (en) | Compositions and methods relating to colon specific genes and proteins | |
AU2002217991A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002236534A1 (en) | Compositions and methods relating to ovary specific genes and proteins | |
AU2002364968A1 (en) | Compositions and methods relating to hepatic specific genes and proteins | |
AU2002357382A1 (en) | Compositions and methods relating to endometrial specific genes and proteins | |
AU2001297804A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2002241557A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002236579A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002332760A1 (en) | Compositions and methods relating to ovary specific genes and proteins | |
AU2002225791A1 (en) | Compositions and methods relating to ovary specific genes and proteins | |
AU2002225911A1 (en) | Compositions and methods relating to ovary specific genes and proteins | |
AU2002253946A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2002241730A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
AU2002331780A1 (en) | Compositions and methods relating to lung specific genes and proteins | |
AU2002239413A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002239412A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002335686A1 (en) | Compositions and methods relating to prostate specific genes and proteins | |
AU2002357391A1 (en) | Compositions and methods relating to endometrial specific genes and proteins |